Select Journal or Resource JAMA & Archives Home JAMA Archives of   Dermatology   Facial Plastic Surgery   Family Medicine (1992-2000)   General Psychiatry   Internal Medicine   Neurology   Neurology and Psychiatry (1919-1959)   Ophthalmology   Otolaryngology—Head & Neck Surgery   Pediatrics & Adolescent Medicine   Surgery JAMA-français JAMA & Archives CME Calendar of Events JAMA Career Center For The Media JAMAevidence Peer Review Congress Student JAMA (1998-2004)

	Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In Vol. 8 No. 3, May 1999   Archives  •  Online Features  Article Links  • Return to Article Downloading the PowerPoint slide may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it. Copyright restrictions may apply. Please see our Conditions of Use. Figure 5. Secondary efficacy outcomes: mean patient-assessed end-of-study effectiveness evaluation (0, poor; 4, excellent) by treatment group. Based on analysis of variance for each of these 3 outcomes, P<.001 for loperamide hydrochloride–simethicone vs each of the other treatment groups. HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP   © 2009 American Medical Association. All Rights Reserved.